Drug Profile
External Guide Sequences
Latest Information Update: 29 Aug 2002
Price :
$50
*
At a glance
- Originator Yale University
- Class
- Mechanism of Action Ribonuclease P stimulants; RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B